Laura Goss

Successfully launched Amvuttra in Rare Disease, ATTR-CM. Exceeded corporate sales goals by focusing on strategic accounts such as Advent Transplant Institute, Baptist Health, University of Florida, and Orlando Health.

Key Achievements

*Ranked YTD #16 for launch of Amvuttra ATTR-CM.

*YTD Amvuttra Growth 107%

*Southeast Team Lead Data Champion

*Southeast Team Lead Conferences

*Selected by Market Access Team to roll out Market Access tool during launch

Rare Disease/Orphan Drug

Launch Wainua in Ultra Rare Disease ATTR-PN. Developing relationships with key opinion leaders at Center of Excellence for ATTR- Mayo Clinic Jacksonville. Utilizing knowledge of complex genetic rare diseases and payer policies to compliantly pull through patients to Wainua.

Key Achievements

*Ranked #3 in Nation SIP Contest Q2, 2024.

*Selected for Field Input Team to collaborate with Marketing and Sales Leadership to develop strategies for successful Wainua launch.

Exceed personal and corporate sales for Fasenra, developing mutually beneficial partnerships with physician offices, hospital infusion centers, and community Alternative Sites of Care (ASOC’s), and establishing new ASOC locations. Persuasively present the benefits of Fasenra to Pulmonologists, Allergists, Immunologists, IDN’S, and Infusion Centers. Distribute weekly reports based on sales analytics to supervisors and all team members to guide new sales initiatives and promotional strategies, and train on new business analytic tools. Act as Field Based Trainer for Jacksonville Team.

Key Achievements

*Exceeded Fasenra sales goals by 104% (2021). Led nation in new referrals for Fasenra #1 YTD (2019), and #2 YTD (2018)

*Handpicked to complete Field Reimbursement Manager Prep Program to further develop strategic mindset in access and reimbursement.

*Selected to train 5 new hires on Biologic products (weekly meetings) and continue to mentor 2 hires 1.5 yrs running.

Advanced to position after demonstrating Biologic expertise, account management, consistent achievement, collaborative relationship-building, and for increasing patient access.

Field Reimbursement Management: Utilized knowledge of local and national payers and specialty pharmacies to compliantly pull patients through to Cinqair. Consistently led with experience in medical criteria and coding, patient-focused reimbursement, prior authorization, and account management.

Sales: Generated sales by establishing buy and bill accounts throughout territory. Successfully sold Cinqair to Pulmonologists, Allergists, IDNs, and Infusion Centers, presenting at in-service training sessions.

Key Achievements

*Exceeded Cinqair sales goal by 115% (2017).

*Ranked #6 in Nation; President's Club contender

Generated Teva product sales by managing Respiratory Portfolio throughout assigned territory to Pulmonologists, Allergists, ENTs, Pediatricians, and Family Practice Physicians. Selected for membership on the Respiratory Sales Specialist Advisory Board (2016), and Champions Council (2016) to develop product sales initiatives based on clinical acumen.

Key Achievements

*Won President's Club for top performance (2014).

*Ranked #2 in final four competition for Proair Respiclick (2016).

*Ranked #7 in Nation, exceeding quota on Respiratory Portfolio: Proair HFA 112%, Qvar 144%, and Qnasl 130%. *Exceeded sales quotas for Respiratory Portfolio (Q1, 2016) for Proair Respiclick 106%, Qvar 103%, and Qnasl 117%.

Managed the largest territory and recognized for exceeding sales objectives as a top performer. Developed and maintained relationships with national thought leaders in rare disease, collaborating on initiatives to improve patient’s quality of life. Educated healthcare professionals on complex biological products, impacting sales, and providing patient education and support. Cultivated and grew Biologic portfolio of products in Hospital Accounts, Distributors, and Specialty Pharmacy.

Key Acheivements

*Ranked #1 President's Club for Gamunex launch (2004).

*Delivered tailored in-services for physicians and pharmacists regarding Kogenate FS (Hemophilia), Gamimune N, and Gamunex (Immune Deficiencies), and Prolastin(Alpha-1 Antitrypsin Deficiency).

I managed and sold Insulin Portfolio including Humalog, and Humalog Mix 75/25 to Endocrinologists, and Family Practice Physicians within territory, consistently delivering high sales results. Ranked in top 25% out of 510 reps in the Diabetes Division.